Coup de theater: the Johnson and Johnson laboratory sentenced to 40.5 million dollars for having defrauded its patients
On the eve of its trial for its role in the opioid crisis, the Johnson & Johnson laboratory agrees to pay 40.5 million dollars to close a particularly embarrassing legal file. And this, in the midst of a Coronavirus pandemic where the laboratory is seeking to sell its vaccines.
Another pharmaceutical giant caught in the act of fraud.
A month ago, the condemnation of Pfizer to a fine of 84 million dollars by the British justice had made the rounds of the world. Since then, Lecourrier-du-soir.com has continued to reveal the big scandals that have shaken Big Pharma in recent months and deliberately concealed by the media for reasons that are totally unknown.
But, apparently, it's not over yet. Because, in recent days, the giant Johnson and Johnson was fined 40 million dollars for its role in the opioid crisis. This is the information that Lecourrier-du-soir.com has obtained from several reliable sources including Fiercepharma.com .
Indeed, according to this media, sued by the State of New Hampshire (United States), Johnson and Johnson ended up capitulating, agreeing to pay 40.5 million dollars to close a legal file in connection with its role. in the opioid crisis that killed more than 50,000 people in the United States.
According to the same source, the State of New Hampshire had taken legal action against this laboratory in 2018, accusing it of having implemented an “aggressive” marketing strategy which allowed it to sell anti-inflammatory drugs. opioid by tricking patients into thinking they were safer than those made by its competitors, which was untrue.
In a press release made public on September 1 and consulted by Lecourrier-du-soir.com , the justice of New Hampshire tells us more. Indeed, the Department of Justice of this American State confirms that the laboratory and the American State have reached an agreement for Johnson and Johnson to pay 40.5 million dollars in damages.
The Department of Justice confirms the implementation of aggressive marketing by the American laboratory to sell its drugs to patients and adds that this marketing strategy was accompanied by a propaganda campaign in which the laboratory made false statements about opioids by denying the idea that his drugs presented no risk of addiction for patients.
And that's not all. Justice accuses the lab of having particularly targeted vulnerable people, namely the elderly. Justifying the heavy fine imposed on the American lab, the justice of New Hampshire accuses, in its press release, Johnson and Johnson of having carried out activities which have considerably contributed to creating “a public nuisance”. The trial is scheduled for September 7 in Merrimack County Supreme Court.
- Source : Sheikh Dieng
